Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

Historical Holders from Q4 2020 to Q3 2025

Symbol
TARS on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
42,194,093
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
44,886,085
Holdings value
$2,667,310,256
% of all portfolios
0%
Number of holders
215
Number of buys
98
Number of sells
-114
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 8.1% $134,159,372 3,424,180 RTW Investments, LP 30 Jun 2025
BlackRock, Inc. 7.4% $153,770,784 3,092,735 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 7.11% +25% $178,290,000 +$38,453,587 3,000,000 +27% Deep Track Capital, LP 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 5.9% $122,052,507 2,454,797 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
MORGAN STANLEY 4.7% $96,628,483 1,943,453 Morgan Stanley 31 Mar 2025
Cowen Financial Products LLC 4.9% $94,926,816 1,909,228 Cowen Financial Products LLC 31 Dec 2024

Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 44,886,085 $2,667,310,256 -$49,486,535 $59.43 215
2025 Q2 46,131,337 $1,868,819,125 +$92,953,952 $40.51 203
2025 Q1 43,564,795 $2,238,109,644 +$155,550,097 $51.37 191
2024 Q4 40,257,261 $2,228,992,305 -$65,425,283 $55.37 192
2024 Q3 43,391,345 $1,426,965,052 +$102,534,235 $32.89 161
2024 Q2 40,066,753 $1,089,006,566 +$6,596,629 $27.18 147
2024 Q1 39,323,641 $1,429,414,516 +$260,798,405 $36.35 155
2023 Q4 32,126,860 $650,570,328 +$49,625,202 $20.25 114
2023 Q3 29,793,106 $529,411,112 +$139,188,159 $17.77 105
2023 Q2 21,435,682 $387,312,097 +$39,178,138 $18.07 92
2023 Q1 20,057,814 $252,130,256 -$6,023,437 $12.57 73
2022 Q4 20,531,051 $300,987,054 +$5,059,618 $14.66 67
2022 Q3 20,489,091 $350,771,070 +$9,266,431 $17.12 72
2022 Q2 19,980,650 $291,715,823 +$98,791,820 $14.6 70
2022 Q1 13,210,299 $222,212,113 -$29,618,514 $16.82 50
2021 Q4 13,072,993 $294,217,317 +$4,316,413 $22.5 43
2021 Q3 12,869,541 $277,366,339 -$12,449,066 $21.55 43
2021 Q2 13,061,656 $378,528,053 +$8,240,890 $28.98 44
2021 Q1 12,761,893 $410,350,129 -$213,790 $32.23 41
2020 Q4 12,759,585 $523,637,183 +$523,637,191 $41.33 39